Betalutin
Nordic Nanovector
['lymphoma', 'dlbcl', 'nordic']
#nordicnanovector announces that the data from the #lymrit3705 phase 1 trial of #betalutin in #relapsed #refractory #diffuselargebcelllymphoma (#dlbcl) will be presented at #eha22 meeting 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.